Status:
COMPLETED
MK0431/ONO-5435 Phase III Clinical Trial -Add-on to Voglibose Study for Patients With Type 2 Diabetes Mellitus (MK0431-104)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Diabetes Mellitus, Non-Insulin-Dependent
Eligibility:
All Genders
20+ years
Phase:
PHASE3
Brief Summary
The phase III clinical trial examines the efficacy, safety, and tolerability of the addition of MK0431/ONO-5435 to Japanese patients with type 2 diabetes mellitus (T2DM) who have inadequate glycemic c...
Eligibility Criteria
Inclusion
- Japanese Patients With Type 2 Diabetes Mellitus, Who Have Inadequate Glycemic Control On Diet/Exercise Therapy And Voglibose Monotherapy
Exclusion
- Patients Have A History Of Type 1 Diabetes Mellitus
Key Trial Info
Start Date :
February 5 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 11 2010
Estimated Enrollment :
133 Patients enrolled
Trial Details
Trial ID
NCT00837577
Start Date
February 5 2009
End Date
August 11 2010
Last Update
May 15 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.